Expression, Characteristics, and Clinical Target Prediction of PIK3C3/ vps34 in Gastric Cancer

PIK3C3/vps34 is downregulated in GC tissues, exerting a pivotal role in tumorigenesis, and is intimately linked with the prognostic trajectory of GC patients. It may serve as a significant biomarker for prognostic evaluation and a promising molecular therapeutic target for GC.

Authors

Institutions

Publication Details

Journal
Current Cancer Drug Targets
Published
2024-10-02
DOI
https://doi.org/10.2174/0115680096334160240916102105
Citations
3
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expression, Characteristics, and Clinical Target Prediction of PIK3C3/ vps34 in Gastric Cancer

Mingxu Da, Chenglou Zhu, Wenhan Liu
3 citations
Current Cancer Drug Targets
PI3K/AKT/mTOR signaling in cancer
0.70
article

Expression, Characteristics, and Clinical Target Prediction of PIK3C3/ vps34 in Gastric Cancer

Mingxu Da, Chenglou Zhu, Wenhan Liu
article en
3 citations

Abstract

PIK3C3/vps34 is downregulated in GC tissues, exerting a pivotal role in tumorigenesis, and is intimately linked with the prognostic trajectory of GC patients. It may serve as a significant biomarker for prognostic evaluation and a promising molecular therapeutic target for GC.

Current Cancer Drug TargetsVol. 25(10)
Gansu Provincial Hospital (CN), Lanzhou University (CN)
Good health and well-being
Openalex Percentile: Top 29%
PI3K/AKT/mTOR signaling in cancer
0.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.